All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
IKENA ONCOLOGY, INC. Last Reported: 5/31/2024 Stock Symbol: IKNA

Business Address

50 NORTHERN AVE.

BOSTON , MA US 02210

Mailing Address

50 NORTHERN AVE.

BOSTON , MA US 02210
Phone Number: 857-343-8292 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $119,894,000.00 $121,277,000.00 $70,868,000.00 $29,329,000.00 $59,919,000.00 $67,074,000.00 $48,487,000.00 $46,877,000.00 $232,217,000.00 $245,899,000.00 $264,004,000.00 $281,010,000.00 $162,491,000.00 $55,860,000.00 $63,530,000.00 $72,113,000.00 --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $3,197,000.00 $3,701,000.00 $3,334,000.00 $3,365,000.00 $3,063,000.00 $3,617,000.00 $6,335,000.00 $3,675,000.00 $4,299,000.00 $5,966,000.00 $4,706,000.00 $2,224,000.00 $3,478,000.00 -- -- -- --
Total Current Assets $178,662,000.00 $200,634,000.00 $160,646,000.00 $141,178,000.00 $160,010,000.00 $177,978,000.00 $199,145,000.00 $216,050,000.00 $236,516,000.00 $251,865,000.00 $268,710,000.00 $283,234,000.00 $165,969,000.00 -- -- -- --
Property Plant and Equipement $2,335,000.00 $2,633,000.00 $2,875,000.00 $3,126,000.00 $3,205,000.00 $3,115,000.00 $2,950,000.00 $2,292,000.00 $2,439,000.00 $2,125,000.00 $2,102,000.00 $2,118,000.00 $1,393,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- $872,000.00 $872,000.00 $872,000.00 $872,000.00 -- -- -- --
Total Assets $192,092,000.00 $215,335,000.00 $171,764,000.00 $152,401,000.00 $172,259,000.00 $190,468,000.00 $211,184,000.00 $227,747,000.00 $247,879,000.00 $261,705,000.00 $278,827,000.00 $293,662,000.00 $168,404,000.00 -- -- -- --
Accounts Payable $2,066,000.00 $3,950,000.00 $1,772,000.00 $2,759,000.00 $2,093,000.00 $2,361,000.00 $4,092,000.00 $2,388,000.00 $2,384,000.00 $1,928,000.00 $2,474,000.00 $2,528,000.00 $2,122,000.00 -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $22,335,000.00 $28,146,000.00 $15,064,000.00 $17,379,000.00 $25,290,000.00 $31,680,000.00 $36,816,000.00 $34,792,000.00 $40,002,000.00 $58,442,000.00 $62,567,000.00 $66,018,000.00 $63,473,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-48,000.00 $-290,000.00 $-456,000.00 $-491,000.00 $-763,000.00 $-1,181,000.00 $-1,104,000.00 $-478,000.00 -- -- -- -- -- -- -- -- --
Accumulated Deficit $-282,385,000.00 $-262,896,000.00 $-245,553,000.00 $-228,438,000.00 $-214,200,000.00 $-200,122,000.00 $-182,784,000.00 $-162,293,000.00 $-145,454,000.00 $-148,251,000.00 $-133,736,000.00 $-121,055,000.00 $-111,339,000.00 -- -- -- --
Total Stockholders' Equity $169,757,000.00 $155,344,000.00 $156,700,000.00 $135,022,000.00 $146,969,000.00 $158,788,000.00 $174,368,000.00 $192,955,000.00 $207,877,000.00 $203,263,000.00 $216,260,000.00 $227,644,000.00 $-101,048,000.00 $-78,500,000.00 $-72,696,000.00 $-68,012,000.00 $-61,463,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $192,092,000.00 $215,335,000.00 $171,764,000.00 $152,401,000.00 $172,259,000.00 $190,468,000.00 $211,184,000.00 $227,747,000.00 $247,879,000.00 $261,705,000.00 $278,827,000.00 $293,662,000.00 $168,404,000.00 -- -- -- --

Statement of Operations

Date 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $59,652,000.00 $14,654,000.00 $15,172,000.00 $15,552,000.00 $64,321,000.00 $18,850,000.00 $15,488,000.00 $14,343,000.00 $47,108,000.00 $34,770,000.00 $21,396,000.00 $10,021,000.00 -- $7,218,000.00 $6,334,000.00 $7,893,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $84,577,000.00 $62,010,000.00 $20,494,000.00 $20,828,000.00 $86,522,000.00 $24,278,000.00 $41,679,000.00 $20,346,000.00 $65,123,000.00 $47,698,000.00 $29,431,000.00 $13,194,000.00 -- $27,595,000.00 $18,534,000.00 $10,403,000.00 --
Loss from Operations $-75,417,000.00 $-53,509,000.00 $-34,005,000.00 $-15,515,000.00 $-70,904,000.00 $-17,876,000.00 $-37,913,000.00 $-16,962,000.00 $-34,138,000.00 $-36,930,000.00 $-22,408,000.00 $-9,720,000.00 -- $-18,466,000.00 $-5,059,000.00 $-7,176,000.00 --
Loss Before Income Taxes $-68,328,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-1.63 $-1.23 $-0.83 $-0.39 $-1.90 $-0.48 $-1.03 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 41,735,081 43,437,844 39,292,710 36,257,493 36,188,420 36,257,074 36,118,415 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-1.63 $-1.23 $-0.83 $-0.39 $-1.90 $-1.51 $-0.57 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 41,735,081 43,437,844 37,783,486 36,257,493 36,188,420 36,257,074 36,118,415 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 230,000,000 -- -- -- --
Common Stock Shares Outstanding 48,258,111 44,104,672 42,299,478 36,257,493 36,257,493 36,257,493 36,251,977 36,109,534 35,975,034 35,877,794 35,859,119 35,851,241 3,096,903 -- -- -- --
Common Stock Value $48,000.00 $44,000.00 $42,000.00 $36,000.00 $36,000.00 $36,000.00 $36,000.00 $36,000.00 $36,000.00 $36,000.00 $36,000.00 $36,000.00 $3,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com